Japan Diabetic Retinopathy Therapeutic Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of diabetes, growing awareness and early diagnosis, advancements in technology and treatment options, government initiatives and healthcare expenditure, and the aging population are the drivers of the diabetic retinopathy therapeutic market. Prominent global players in the market include Novartis AG, Roche Holdings AG, Regeneron Pharmaceuticals, Bayer AG, Allergan plc (AbbVie Inc.), Alimera Sciences, Bausch Health Companies Inc., Topcon Corporation, Carl Zeiss Meditec AG and NIDEK Co., Ltd.
Japan Drugs Addiction Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drug addiction market is driven by rising substance usage, increased awareness and public health campaigns, breakthroughs in treatment methods, government initiatives and legislation, and the high frequency of co-occurring mental health issues. Indivior PLC, Alkermes plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Orexo AB, Mylan N.V., Glenmark Pharmaceuticals, Accord Healthcare Ltd., and Camurus AB are global players in the Drug Addiction Market.
Japan Dry Eye Medication Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of dry eye, aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medication market. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in Dry Eye Medication Market.
Japan Encephalitis Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of encephalitis, growing awareness and immunization programs, technological advancements in vaccine development, global travel and migration, and government support and funding are the drivers of the encephalitis vaccines market. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.
Japan End-stage renal disease (ESRD) Market Analysis is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the End-stage renal disease (ESRD) market include the increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, growing demand for kidney transplantation, government initiatives and healthcare policies supporting renal care, and the aging population. Global Players in the ESRD Market are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., Medtronic plc, Terumo Corporation and Rockwell Medical, Inc.
Japan Endometriosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the Endometriosis Drugs market include the increasing prevalence of endometriosis, growing awareness and diagnosis, demand for effective pain management, technological advancements in drug development, and supportive government initiatives. These factors contribute to market growth by addressing unmet needs and improving access to treatment options for endometriosis patients. Global Players in the Endometriosis Drugs Market are AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Teva Pharmaceutical Industries Ltd., Merck & Co. and Takeda Pharmaceutical Company Limited.
Japan Enzymatic Wound Debridement Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing prevalence of chronic wounds and diabetic ulcers, Advancements in enzymatic debridement technology, increasing demand for non-invasive and painless wound debridement methods and rising geriatric population prone to chronic wounds are drivers in Enzymatic Wound Debridement Market. Global Companies in the Enzymatic Wound Debridement Market are Smith & Nephew plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Paul Hartmann AG, Hollister Incorporated, Integra LifeSciences Corporation, Organogenesis Inc. and Misonix Inc.
Japan Enzyme Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of enzyme-related disorders, advances in drug discovery and development, a greater emphasis on personalized therapy, and increased research spending and collaborations are driving the enzyme inhibitors market. Novartis International AG, Roche Holding AG, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi S.A., Boehringer Ingelheim International GmbH, Bayer AG, Takeda Pharmaceutical Company Limited, AbbVie Inc., and Merck KGaA are the global participants in the enzyme inhibitors market.
Japan Epigenetics Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving this market growth include an increase in the incidences of infectious diseases, cancer, chronic conditions, and genetic conditions; rising healthcare spending, which, according to the American Medical Association, will exceed $187.6 billion in 2021; and growing interest in bioinformatics, the market for which will reach $10 billion in revenue in 2022. Global key players in the epigenetics market include Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Merck KGaA, and Abcam plc.
Japan Epilepsy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market. Some of the prominent global players in the epilepsy drugs market include Pfizer Inc., UCB S.A., GlaxoSmithKline plc, Novartis AG, and Eisai Co., Ltd.
Japan Gastroesophageal Reflux Disease (GERD) Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The high prevalence of GERD, rising awareness and diagnostic rates, technology improvements, and lifestyle variables are all driving factors in the Gastroesophageal Reflux Disease (GERD) medications market. Some prominent global players in the Gastroesophageal Reflux Disease (GERD) drugs market include AstraZeneca PLC, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., Mylan N.V., Perrigo Company plc, and Sun Pharmaceutical Industries Ltd.
Japan Gastrointestinal Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of gastrointestinal problems, caused by factors such as changing lifestyles, dietary habits, and an ageing population, is one of the main drivers for gastrointestinal medications. Technological advances in drug research and targeted medicines, which provide more effective treatment alternatives, also contribute to market growth. Furthermore, as people become more aware of and diagnose gastrointestinal diseases, the need for medications to treat these conditions grows. Pfizer Inc., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., and Allergan plc are among the major global competitors in the gastrointestinal drugs market.
Japan Generic and Biosimilar Pharmaceutical Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The generic and biosimilar pharmaceutical market is driven by cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.
Japan Glaucoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of glaucoma, caused by factors such as an ageing population and rising awareness, is a driver of the glaucoma medications industry. Drug delivery system technological improvements help to increase treatment choices. Novartis AG, Pfizer Inc., Santen Pharmaceutical Co., Allergan (AbbVie Inc.), Bausch Health Companies Inc., Alcon (a part of Novartis AG), Merck & Co., Aerie Pharmaceuticals, Sun Pharmaceutical Industries Ltd., and Santen Inc. are the global players in the Glaucoma Drugs Market.
Japan Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications. Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH and Zealand Pharma A/S are global key players in the market.
Japan Glucaric Acid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the glucaric acid market include the growing demand in various industries, driven by its applications and eco-friendly properties, increased consumer awareness of sustainability, and ongoing research and development efforts to explore new applications and production methods for glucaric acid. Global Players in Glucaric Acid Market are Rennovia Inc., Rivertop Renewables, Haihang Industry Co., Hebei Long Hai Import and Export Trade Co., Haihang Industry (Jinan) Co., Alfa Chemistry, Tokyo Chemical Industry Co., AK Scientific and Biosynth Carbosynth.
Japan Glutathione Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of chronic diseases, demand in the cosmetics and beauty industry, and sports nutrition and performance enhancement are key drivers of the glutathione market. Kyowa Hakko Bio Co., Shandong Jincheng Biological Pharmaceutical Co., Kohjin Life Sciences, NOW Health Group, Merck KGaA, Kaiping Genuine Biochemical Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shenzhen GSH Bio-Technology Co., Energetic Nutrition, and TCI Chemicals are the global players in the glutathione market.
Japan Gram Positive Bacterial Infections Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gram-positive bacterial infections market include the increasing prevalence of these infections, the emergence of antibiotic resistance, technological advancements in diagnostics and treatments, and the growing healthcare infrastructure, leading to higher demand for effective treatments and the need for innovative solutions to combat these infections. Global Players in Gram positive Bacterial Infections market are Pfizer Inc., Merck & Co., GlaxoSmithKline, Novartis AG, Sanofi S.A., Johnson & Johnson Services, AbbVie Inc., Bayer AG, AstraZeneca plc and Eli Lilly and Company.
Japan Gynecology Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gynecology drugs market include the increasing prevalence of gynecological disorders, growing awareness and focus on women's health, technological advancements, and supportive government initiatives promoting women's healthcare. Key Global Players in Gynecology Drugs Market are Bayer AG, Pfizer Inc., Merck & Co., Novartis AG, Johnson & Johnson, AbbVie Inc., Allergan plc, Eli Lilly and Company, AstraZeneca plc and GlaxoSmithKline plc.
Japan H1N1 Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the H1N1 vaccines market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.
Japan Haematology Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing frequency of blood disorders, technological improvements, the growing elderly population, and increased desire for customised medicine and focused therapies are key drivers of the haematology market. Abbott Laboratories, Sysmex Corporation, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), HORIBA Ltd., Ortho Clinical Diagnostics, and Agilent Technologies are the global players in the haematology market.
Japan Hangover Rehydration Supplements Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing ageing population and prevalence of chronic diseases, breakthroughs in medication discovery and technology, and increased access to healthcare in emerging economies are all key drivers of the Hangover Rehydration Supplements Market. Gatorade (PepsiCo), Pedialyte (Abbott Laboratories), Liquid IV, Flyby, Blowfish for Hangovers, Cheers Health Inc., Bytox, Morning Recovery, Resync Recovery Blend, and Hydrant are the global key players in the Hangover Rehydration Supplements Market.
Japan Head and Neck Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the head and neck cancer drugs market in the USA include the increasing incidence of head and neck cancer, advancements in treatment options, rising demand for personalized medicine, and supportive government initiatives. Global Companies in Head and Neck Cancer Drugs Market are Bristol Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Roche Holding AG, Takeda Pharmaceutical Company Limited, Bayer AG, AbbVie Inc. and Eisai Co., Ltd.
Japan Heart Failure Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drivers of the heart failure drugs market include the increasing prevalence of heart failure, the aging population, advancements in drug therapies, rising awareness and diagnosis, and supportive government initiatives. Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, Merck & Co., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Bayer AG, GlaxoSmithKline plc and Amgen are global key players in Heart Failure Drugs market.
Japan Hematopoietic Stem Cell Transplantation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Two significant drivers driving the global market expansion for hematopoietic stem cell transplantation are leukaemia and lymphoproliferative disorders. Rising technical advancements and significant companies spending more money on R&D are expected to drive the market. Some of the major key players are Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories etc.